Diffusion MRI Tractography Through Brain Lesions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing tractography methods struggle to accurately determine brain connections in patients with neurodegenerative diseases like multiple sclerosis due to difficulties in tracking fibers through lesions and plaques, leading to inaccurate fiber track damage assessment.
Innovation Solution
A system and method that enhances diffusion MRI images using an enhancement engine to model fiber architecture, segment anatomical images, and generate tractography, enabling accurate tracking of neural fibers through damaged areas by converting fiber orientation distribution functions into amplitude images and applying kernels to solve the diffusion equation, followed by filtering and scoring the damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional tractography methods are used on damaged brain tissue, then the process is simple and fast, but the accuracy of fiber tracking through lesions is poor
Solution Approach 1:
The patent segments the brain into white matter regions and lesions using anatomical images. By dividing the damaged brain tissue into tract regions and lesion regions, the system can apply different processing strategies to each segment, improving fiber tracking accuracy through lesions while managing computational complexity through regional specialization.
Solution Approach 2:
The patent performs preliminary enhancement of diffusion-weighted images by convolving with a kernel to generate enhanced images before tractography. This preliminary action improves the quality of diffusion data in lesion regions, enabling more accurate fiber tracking to be performed in subsequent processing steps.
2Measurement precision
If diffusion MRI images are enhanced using kernel convolution, then fiber architecture modeling accuracy improves, but processing time and computational resources increase
Solution Approach 1:
The patent applies kernel convolution enhancement selectively to improve fiber orientation accuracy in specific regions where lesions are present. By focusing computational resources on enhancing diffusion-weighted images in problematic areas rather than uniformly processing the entire brain, the system achieves improved fiber architecture modeling while reducing overall processing time.
3Measurement precision
If tractography is performed through lesions using enhanced diffusion images, then damage quantification accuracy improves, but the complexity of the analysis pipeline increases
Solution Approach 1:
The patent segments tractography results into fibers traversing lesions and fibers not traversing lesions by comparing tract locations with lesion masks. This segmentation enables accurate quantification of damage by calculating the proportion of damaged fibers, while the modular approach to segmentation keeps the pipeline complexity manageable through clear separation of analysis steps.
Solution Approach 2:
The system uses registered anatomical images and lesion masks as feedback to evaluate and quantify tract damage. By continuously referencing the segmented lesion regions during tractography analysis, the system can accurately assess which fibers are damaged and calculate damage metrics, improving quantification accuracy through iterative feedback from the segmented anatomical data.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise quantification of neurological damage by generating clinical scores based on tractography, allowing for reliable patient comparisons and disease progression monitoring.
Implementation Method 1
convolving the diffusion-weighted image with a kernel to generate an enhanced diffusion-weighted image
Data Source
AI summary
The present disclosure discusses systems and methods for identifying biomarkers that can help with the diagnosis, prognosis, and treatment choices of patients with neurodegenerative diseases. Diffusion based magnetic resonance imaging can often fail for patients with a neurodegenerative disease because parameters fractional anisotropy, mean diffusivity, and radial diffusivity are based on simple models that can fail in the presence of neurodegeneration, such as demyelination. The present disclosure discusses systems and methods that enhance dMRI images and enable tractography to be performed on images of a damaged nervous system. The damaged tracks identified by the present system can be used as a biomarker for the assessment of patients. In some implementations, the biomarkers are converted into clinical scales that can be used to compare patients to one another or over time.